Product information and disease descriptionPlace of product in therapyDisease description
Epidemiology
31 evidence topics · 32 sources
RP-A501 (AAV9.LAMP2B)
Danon disease
- Manufacturer
- Rocket Pharmaceuticals
- Regulatory submission
- BLA planned for late 2028
- Launch
- Anticipated in mid-2029
- Last updated